Patel, A. A., Yoon, J. J., Johnston, H., Davidson, M. B., Shallis, R. M., Chen, E. C., Burkart, M., Oh, T. S., Iyer, S. G., Madarang, E., Muthiah, C., Gross, I., Dean, R., Kassner, J., Viswabandya, A., Madero-Marroquin, R., Rampal, R. K., Guru Murthy, G. S., Bradley, T., … Odenike, O. (2024). Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood Advances, 8(13), 3468–3477. https://doi.org/10.1182/bloodadvances.2024012880
Subjects:
Myeloproliferative Disorders
(MeSH)
Molecular Pathogenesis of Myeloproliferative Disorders
(OpenAlex Topic)
Acute Myeloid Leukemia
(OpenAlex Topic)
Efficacy and Resistance in CML Treatment
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2024012880
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex